Primary small cell oesophageal carcinoma: A retrospective study of different ‎treatment modalities

Table 3 Clinical and treatment details of the five patients who received concurrent chemoradiotherapy

Patient	Age	Sex	PS	Site	CT	Cycles (n)	RT dose	Response	Relapse	Alive1	Survival (mo)
1	83	M	0	Low	PE	4	50 Gy in 25 Fr	PR	Local	1	45
2	79	M	1	Low2	CE	4	45 Gy in 25 Fr	CR	Liver	1	38
3	73	M	1	Low	PE	3	45 Gy in 25 Fr	CR	None	0	92
4	58	M	1	Low	CE	4	50 Gy in 25 Fr	CR	Local3	0	110
5	79	M	0	Low	CE	4	45 Gy in 25 Fr	PR	Liver	1	40

¹1 = Died, 0 = Otherwise.

²Mixed pathology initially, biopsy confirmed recurrence of squamous cell carcinoma only.

³New primary with adenocarcinoma; patient had salvage surgery. CE: Cisplatin and etoposide; CT: Chemotherapy; Fr: Fractions; M: Male; PE: Carboplatin and etoposide; PS: Performance status; PR: Partial response; RT: Radiotherapy.